Berlin — German chemical and pharmaceutical giant Bayer said on Thursday it would slash 12,000 jobs in a major restructuring following the mammoth takeover of Monsanto, enabling it to save €2.6bn a year from 2022. The planned job cuts will affect about one in every 10 of the group's 118,200 posts, “a significant number of them in Germany”, said the group in a statement. Bayer swallowed Monsanto in June in one of Germany's biggest corporate takeovers to date, at a cost of €63bn. But barely two months later, a court ruling in the US left Bayer with multimillion-dollar damages to pay as the judge found that its newly acquired subsidiary, Monsanto, should have warned a user about cancer risks from its herbicide, Roundup. Announcing details of the restructuring, Bayer said it planned to exit its animal health business, in order to concentrate resources on its core businesses of pharmaceuticals, consumer health and crop science. It is also looking at letting go of its Coppertone sun care ...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Times Select.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now